The recurrent ischemia rate was lower than thrombolysis and PTCA.
术后复发心肌缺血发生率较溶栓治疗和单纯PTCA低。
Methods The direct PTCA and follow-up on 76 Q-wave type AMI patients were performed.
方法：对76例急性Q波型心肌梗塞患者行直接PTCA治疗并随访。
It suggested that the sympathetic activity was diminished and the vagal activity was raised after PTCA.
说明PT CA术后交感神经活性降低，迷走神经活性增强。
This paper reviews the significance and methodology of pharmacological myocardial protection during PTCA.
并对冠状动脉成形术时药物心肌保护的意义、方法等进行了扼要的综述。
For high risk AMI patients, the emergency PTCA can decrease mortality and improve short-term and long-term prognosis.
对危重ami病人急诊ptca治疗可降低死亡率，并可改善病人的近远期预后。
With the development of stenting operation, various PTCA accessories have been involved in a wide rage of applications.
随着支架植入手术在国内的迅猛发展，各种与手术相配套的介入配件得到了广泛的应用。
P27Kipl restrains the proliferation of VSMC obviously and is prospective to become a new means to cure restenosis after PTCA.
P 27蛋白的高表达可显著抑制血管平滑肌细胞增殖，有望成为治疗PT CA后再狭窄的新手段。
Objective: To investigate the effect of basic fibroblast growth factor on matrix metalloproteinases and restenosis after PTCA .
目的：探讨碱性成纤维细胞生长因子对基质金属蛋白酶表达的影响及其在球囊术后再狭窄中的作用。
The in-stent restenosis is one of the main complications in coronary artherosclerotic heart disease patients after PTCA and PCI.
术后靶血管管腔再狭窄是冠状动脉介入治疗术的主要并发症，如何有效预防再狭窄已成为目前介入心脏医学界的主要课题之一。
Authors also found that restenosis after PTCA was rare in simple coronary lesions, but then it was common in complex coronary lesions.
还发现，单纯型病变在经皮腔内冠状脉动脉成形术后，很少发生再狭窄，但复杂型则常发生再狭窄。
Objective: To probe probe the clinical effect and mechanism of Tongxinluo capsule in preventing and treating coronary restenosis after PTCA.
目的：旨在探讨通心络胶囊防治经皮腔内冠状动脉成形术后再狭窄的临床作用及机制。
If the stenosis of infarct artery exists more than 90% after intracoronary thrombolysis, it is better to perform the PTCA as early as possible.
在实施冠状动脉溶栓后，对于残留严重狭窄的病人经冠脉成形术可以达到比较理想的效果。
Conclusions There are the characters of more coronary artery ectasia, and more slow reflow phenomenon in PTCA related vessel in smoking patients.
结论吸烟患者冠脉病变特点为冠脉瘤样扩张或冠脉扩张症多发。吸烟患者PT CA术中相关血管慢血流现象的发生率较高。
Objective: To study the effective therapeutic method in patients with acute myocardium infarction (AMI) without indication of PTCA and thrombolysis.
目的：探讨无ptca、溶栓适应证急性心肌梗塞(ami)患者的有效治疗方法。
As compared with thrombolytic therapy in the management of acute MI, mortality and nonfatal MI rates typically are considerably lower for primary PTCA.
与溶栓治疗相比，急性心肌梗死时采用PT CA治疗，患者的死亡率和非致死性心肌梗死的发生率明显降低。
However, death and mi rates typically are similar in patients treated with medications or PTCA, and this trend represents a recurring theme in the literature.
但是，两组患者的死亡率和心肌梗塞发生率却很接近，这一点在各类文献中可见类似报道。
The authors reported prevention, observation and nursing of reperfusion arrhythmia occurred in 55 patients with acute myocardial infarction undergoing PTCA and angioplasty implant.
笔者总结了55例急性心肌梗死患者经皮冠状动脉腔内成形术（PTCA）及支架植入术中出现再灌注心律失常的防治、观察和护理。
Objective To evaluate the clinical efficiency of percutaneous transluminal coronary angioplasty (PTCA) and intracoronary stent on the treatment of acute myocardial infarction (AMI).
目的评价经皮冠脉腔内成形术(PTCA)及冠脉内支架术治疗急性心肌梗死的临床疗效。
Objective to study the current status of life quality of patients after PTCA and stent implantation and its influence factors, in order to guide these patients for better life quality.
目的描述经皮冠状动脉成形术(PTCA)及冠脉内支架置入后患者生活质量的现状并调查影响患者生活质量的因素，以有助于健康服务者指导患者提高生活质量。
Objective To observe the active change of the platelet in the coronary circulation before and after PTCA in the patients with coronary heart disease in order to provide a guide to clinical drug usage.
目的研究冠心病患者经皮冠状动脉腔内成形术（PTCA）前后，冠状循环中血小板的变化，为临床用药提供参考。
Objective To observe the active change of the platelet in the coronary circulation before and after PTCA in the patients with coronary heart disease in order to provide a guide to clinical drug usage.
目的研究冠心病患者经皮冠状动脉腔内成形术（PTCA）前后，冠状循环中血小板的变化，为临床用药提供参考。
应用推荐